|Articles|October 23, 2019
Monitoring of transdermal drug delivery in skin using the Renishaw Biological Analyser
Author(s)Renishaw, Inc.
Detecting the presence and depth of penetration of drug compounds in skin can prove challenging, current technologies fail to achieve adequate penetration through layers of dermal tissue. In this study, Raman spectroscopy using the Renishaw Biological Analyser - RA816 confirmed the presence of a topical compound in the epidermis and reticular dermis with high specificity and sensitivity.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
3
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
4
How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems
5
